Drug Profile
Research programme: bacterial vaccines - ImmunoBiology
Alternative Names: MenBioVax™; T-BioVax™Latest Information Update: 28 Dec 2021
Price :
$50
*
At a glance
- Originator ImmunoBiology
- Class Bacterial vaccines; Heat shock proteins
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Clostridium difficile infections; Helicobacter infections; Meningococcal infections; Tuberculosis
Most Recent Events
- 28 Dec 2021 No recent reports of development identified for preclinical development in Clostridium-difficile-infections(Prevention) in United Kingdom
- 28 Dec 2021 No recent reports of development identified for preclinical development in Helicobacter-infections in United Kingdom
- 28 Dec 2021 No recent reports of development identified for preclinical development in Meningococcal-infections in United Kingdom